GRAIL · 15 hours ago
Payer Engagement Account Director (Market Access) #4538
GRAIL is a healthcare company pioneering new technologies to advance early cancer detection. They are seeking a highly driven Payer Engagement Account Director to own and advance a pipeline of payer opportunities and drive payer engagements forward to achieve tangible outcomes.
BiotechnologyHealth CareHealth DiagnosticsMedicalMedical Device
Responsibilities
Own and actively drive a defined pipeline of payer opportunities, with clear accountability for progress, outcomes, and timelines
Initiate, build, and expand relationships with assigned payer accounts, proactively identifying opportunities to advance discussions toward pilots, data evaluations, and access-enabling activities
Lead payer meetings from initial outreach through follow-up execution, ensuring momentum is maintained and next steps are clearly defined
Translate payer interest into concrete deliverables, including pilots, collaborations, or agreements, in close partnership with the Senior Director, Payer Engagement
Navigate complex payer organizations to identify and engage key clinical, economic, and decision-making stakeholders
Surface payer needs, objections, and decision criteria early, and work cross-functionally to address them efficiently
Partner with Market Access, HEOR, Medical Affairs, Commercial, Government Affairs, and clinical development teams to support payer-driven evidence and access requirements
Prepare and deliver compelling, compliant payer-facing materials that clearly articulate clinical and economic value
Maintain disciplined pipeline management, including documentation of payer interactions, progress, risks, and next steps
Represent the company with credibility, urgency, and professionalism in all payer interactions
Qualification
Required
Bachelor's degree required
10+ years of experience in payer engagement, market access, managed care, or healthcare account leadership
Demonstrated track record of successfully closing payer negotiations that resulted in meaningful, expanded insurance coverage
This position will cover markets and institutions across the U.S., and candidates must be able to travel a minimum of 40% of the time
Preferred
Advanced degree (MBA, MPH, PharmD, MD, PhD) preferred
15+ years of experience in payer engagement, market access, managed care, or healthcare account leadership
Strong understanding of U.S. payer decision-making, medical policy, reimbursement, and access pathways
Proven ability to operate independently, prioritize effectively, and maintain momentum across multiple active opportunities
Comfort with ambiguity and experience working in growth-stage or evolving commercial environments
Excellent communication skills, executive presence, and stakeholder management abilities
Experience in biotech, diagnostics, pharma, or healthcare technology
Exposure to payer pilots, value-based arrangements, or evidence-generation collaborations
Familiarity with HEOR, real-world evidence, and clinical development processes
Benefits
Flexible time-off or vacation
A 401(k) retirement plan with employer match
Medical, dental, and vision coverage
Carefully selected mindfulness programs
Company
GRAIL
Grail is a healthcare company that develops pan-cancer screening tests designed to detect cancers at an early stage.
H1B Sponsorship
GRAIL has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (21)
2024 (26)
2023 (23)
2022 (46)
2021 (25)
2020 (9)
Funding
Current Stage
Public CompanyTotal Funding
$2.44BKey Investors
Samsung C&T Corporation,Samsung Electronics6 Dimensions Capital,Ally Bridge Group,Hillhouse Investment,Huangpu River CapitalARCH Venture Partners
2025-10-20Post Ipo Equity· $325M
2025-10-16Post Ipo Equity· $110M
2024-06-13IPO
Leadership Team
Recent News
The Motley Fool
2026-01-23
2026-01-16
2026-01-14
Company data provided by crunchbase